KD Smart contains a 1:4 ratio of EPA:DHA.
Photo © iStockphoto.com/Rinelle
Omega-3 ingredients supplier KD Pharma (Bexbach, Germany) has launched KD Smart, a prenatal omega-3 oil formulated with the same ratio of omega-3 fatty acids EPA and DHA contained in mother’s milk.
Specifically, the ingredient contains a 1:4 ratio of EPA:DHA. “KD Smart is an important product for us,” said Rene Kamminga, vice president, nutrition, KD Pharma, in a press release. “DHA plays a critical role in eye and cognitive health starting right from early development and continuing on throughout life. This particular product is designed to ensure expecting or nursing mothers receive sufficient DHA for both themselves and their growing baby.”
The company cites studies showing that DHA is especially needed during gestation and says the buildup of DHA in the infant’s brain, eye retina, and throughout the body happens most rapidly from gestation through the age of two. Because the body does not produce significant levels of DHA or EPA, supplementation during the prenatal stage is crucial, it adds.
Earlier this year, Nutritional Outlook reported on a recent meta-analysis concluding that prenatal omega-3 fatty acid consumption may help prevent preterm delivery. The study was published in the European Journal of Obstetrics & Gynecology and Reproductive Biology.
Also read:
Widespread Omega-3 Usage Could Save €12.9 Billion in Annual EU Healthcare Costs, Study Suggests
Adults Should Consume 500 mg EPA and DHA Omega-3s Daily, GOED Says
High-Priority Nutrients for Kids
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine
jennifer.grebow@ubm.com
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.
OmniActive partners with CRN to raise awareness about macular carotenoids for prenatal health
May 6th 2024OmniActive Health Technologies has announced a partnership with the Council for Responsible Nutrition to educate and raise awareness about the role of lutein and zeaxanthin in supporting maternal and fetal health during pregnancy among obstetricians, gynecologists, and other maternal healthcare practitioners.